dexmedetomidine has been researched along with Pneumonia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nie, Y; Shan, SQ; Wang, BQ; Wang, L; Yu, J; Zhu, CH | 1 |
| Huang, J; Ji, M; Wang, J | 1 |
| Chen, JS; Cheng, YJ; Hsu, YC; Lu, YF; Wang, ML; Wu, CY; Yang, FS | 1 |
| Benedict, NJ; Kane-Gill, SL; Wong, A | 1 |
| Liu, H; Liu, T; Wu, D; Yang, Y; Zhang, Q | 1 |
| Adjepong, YA; Lukens, C; Manthous, CA; Musial, B; Perez, R; Stewart, R | 1 |
| Gong, C; Jing, G; Liu, Z; Ning, Q; Wang, Q; Wang, Y; Zhang, Y; Zhao, W | 1 |
| Hanna, B; Marino, BS; Nathan, AT; Nicolson, SC | 1 |
| Hanci, V; Sipahi, EY; Turan, IÖ; Yurdakan, G; Yurtlu, S | 1 |
| Multz, AS | 1 |
2 trial(s) available for dexmedetomidine and Pneumonia
| Article | Year |
|---|---|
Effects of dexmedetomidine combined with citrate sufentanil on the prognosis of patients with severe pneumonia and respiratory failure requiring mechanical ventilation.
Topics: Aged; Analgesics, Opioid; Dexmedetomidine; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Hypnotics and Sedatives; Interleukin-6; Male; Malondialdehyde; Middle Aged; Oxygen; Partial Pressure; Pneumonia; Prognosis; Respiration, Artificial; Respiratory Insufficiency; Severity of Illness Index; Sufentanil; Tumor Necrosis Factor-alpha | 2021 |
Effects of Dexmedetomidine Infusion on Inflammatory Responses and Injury of Lung Tidal Volume Changes during One-Lung Ventilation in Thoracoscopic Surgery: A Randomized Controlled Trial.
Topics: Aged; Dexmedetomidine; Female; Humans; Male; Middle Aged; One-Lung Ventilation; Pneumonia; Thoracoscopy; Tidal Volume | 2018 |
8 other study(ies) available for dexmedetomidine and Pneumonia
| Article | Year |
|---|---|
Dexmedetomidine reduces ventilator-induced lung injury via ERK1/2 pathway activation.
Topics: Animals; bcl-2 Homologous Antagonist-Killer Protein; Bronchoalveolar Lavage Fluid; Cytokines; Dexmedetomidine; Disease Models, Animal; Lung; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; Pneumonia; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Ventilator-Induced Lung Injury | 2020 |
Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal.
Topics: Adult; Alcohol Withdrawal Delirium; Alcohol Withdrawal Seizures; Antipsychotic Agents; Benzodiazepines; Cross Infection; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Intensive Care Units; Length of Stay; Male; Middle Aged; Pneumonia; Propofol; Respiration, Artificial; Retrospective Studies | 2015 |
Effects of dexmedetomidine on the protection of hyperoxia-induced lung injury in newborn rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Animals, Newborn; Aquaporin 1; Cytokines; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Hyperoxia; Inflammation Mediators; Lung; Lung Injury; Macrophages; Pneumonia; Pulmonary Edema; Rats, Sprague-Dawley | 2015 |
Outcomes of Patients with Alcohol Withdrawal Syndrome Treated with High-Dose Sedatives and Deferred Intubation.
Topics: Adult; Alcohol Withdrawal Seizures; APACHE; Central Nervous System Depressants; Cohort Studies; Critical Illness; Dexmedetomidine; Ethanol; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Intensive Care Units; Intubation, Intratracheal; Length of Stay; Logistic Models; Lorazepam; Male; Midazolam; Middle Aged; Pneumonia; Propofol; Respiration, Artificial; Retrospective Studies; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 2016 |
Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway.
Topics: Adrenergic alpha-2 Receptor Agonists; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Bungarotoxins; Dexmedetomidine; Interleukin-6; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Pneumonia; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |
Novel use of dexmedetomidine in a patient with pulmonary hypertension.
Topics: Adolescent; Analgesics, Non-Narcotic; Blood Gas Analysis; Conscious Sedation; Dexmedetomidine; Female; Humans; Hypertension, Pulmonary; Hypnotics and Sedatives; Pneumonia; Treatment Outcome | 2008 |
Protective effect of dexmedetomidine in a rat model of α-naphthylthiourea-induced acute lung injury.
Topics: Acute Lung Injury; Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Disease Models, Animal; Drug Interactions; Lung; Male; Pleural Effusion; Pneumonia; Pulmonary Edema; Rats; Rats, Wistar; Rodenticides; Thiourea | 2012 |
Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal.
Topics: Acinetobacter Infections; Adult; Analgesics, Opioid; Dexmedetomidine; Fentanyl; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Lorazepam; Male; Pneumonia; Psychomotor Agitation; Respiratory Distress Syndrome; Substance Withdrawal Syndrome; Substance-Related Disorders; Ventilator Weaning; Ventilators, Mechanical | 2003 |